GENEVA, March 7 (Reuters) - Patent filings slipped last year by nearly 2% in the first fall in 14 years amid economic uncertainty, the U.N. patent agency said on Thursday, in a move it described as
The FTC issued a statement Thursday saying that brand drug manufacturers could be harming competition in the generic market by improperly listing patents in the Food and Drug Administration’s “Orang...
have been granted. Moreover, the subsequent invalidation of the patent was the result of administrative and judicial review, which cannot retroactively prove malice at the time of filing. The appeals
total 1 pages, 3 items